European Hematology Association (EHA) CRTH 2026 cohort completed the program and improved ideas on good trial design, accurate budgeting, project pitching to pharma, and patient communication.

Borderless Hematology means creating an environment where knowledge and expertise have unlimited potential. It's where seasoned experience converges with youthful vigor, facilitating mutual inspiration in a seamless exchange of knowledge and collective learning. Through Borderless Hematology, we empower each member and foster a sense of shared ownership. This shapes not only the field of hematology, but also the lives of patients who depend on us. The future of hematology is within our reach. 𝗢𝘂𝗿 𝗠𝗶𝘀𝘀𝗶𝗼𝗻: "Towards prevention, cure, and quality of life for all patients with blood disorders." 𝗢𝘂𝗿 𝗛𝗶𝘀𝘁𝗼𝗿𝘆 - Conceptualized in 1987 - Launched in 1990 - Formally established in 1992 Over the years, initiatives led by our association and members have positioned us at the forefront of hematology in Europe. Progress in education, training, research support, and patient care have helped to further advance this specialty, so vital to our health. We're a global network, and we actively collaborate with national and international medical associations and societies, and with European authorities to further hematology interests. 𝗞𝗲𝘆 𝗔𝗰𝘁𝗶𝘃𝗶𝘁𝗶𝗲𝘀 - Knowledge: Advancing harmonized hematology education across Europe through the European Hematology Curriculum and the EHA Campus - Connection: Organizing the annual EHA Congress, attended by professionals from all over the world - Clinical excellence: Publishing HemaSphere, our open access journal and EHA's Clinical Practice Guidelines - Advocacy: Strengthening hematology's voice in Europe by furthering its interests at the highest level - Research: Support researchers with generous funding programs and bespoke trainings

Founded 1992